Advanced search
Publication Cover
Journal of Medical Economics Volume 20, 2017 - Issue 7
Submit an article Journal homepage
2,149
Views
20
CrossRef citations to date
0
Altmetric
Oncology

The cost-effectiveness of alectinib in anaplastic lymphoma kinase-positive (ALK+) advanced NSCLC previously treated with crizotinib

J. J. CarlsonUniversity of Washington, Seattle, WA, USA; Correspondence[email protected]
,
W. CanestaroUniversity of Washington, Seattle, WA, USA;
,
A. RaveloGenentech, Inc., South San Francisco, CA, USA
&
W. WongGenentech, Inc., South San Francisco, CA, USA
Pages 671-677 | Received 19 Jan 2017, Accepted 28 Feb 2017, Published online: 23 Mar 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.